Evidence map›Paper›PMID 39482536›Full record

ArticleExperimental & molecular medicine2024

MYH1 deficiency disrupts outer hair cell electromotility, resulting in hearing loss.

Jinsei Jung, Sun Young Joo, Hyehyun Min, Jae Won Roh, Kyung Ah Kim, Ji-Hyun Ma, John Hoon Rim, Jung Ah Kim, Se Jin Kim, Seung Hyun Jang and 8 more

Abstract read
In one paragraph

Article in Experimental & molecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Jinsei Jung *Department of Otorhinolaryngology, Brain Korea 21 PLUS Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.ORCID 0000-0003-1906-6969
Sun Young Joo *Institute for Lee Won Sang Yonsei Ear Science, Seoul, Republic of Korea.
Hyehyun Min *Department of Anatomy, Brain Korea 21 PLUS Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.
Jae Won Roh *Department of Pharmacology, Brain Korea 21 PLUS Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.
Kyung Ah KimDepartment of Nanobioengineering, Incheon National University, Incheon, Korea.
Ji-Hyun MaDepartment of Anatomy, Brain Korea 21 PLUS Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.
John Hoon RimDepartment of Pharmacology, Brain Korea 21 PLUS Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.
Jung Ah KimInstitute for Lee Won Sang Yonsei Ear Science, Seoul, Republic of Korea.
Se Jin KimInstitute for Lee Won Sang Yonsei Ear Science, Seoul, Republic of Korea.
Seung Hyun JangInstitute for Lee Won Sang Yonsei Ear Science, Seoul, Republic of Korea.
Young Ik KohDepartment of Pharmacology, Brain Korea 21 PLUS Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.
Hye-Youn KimDepartment of Pharmacology, Brain Korea 21 PLUS Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.
Ho LeeGraduate School of Cancer Science and Policy, National Cancer Center, Goyang-si, Republic of Korea.ORCID 0000-0001-5573-742X
Byoung Choul KimDepartment of Nanobioengineering, Incheon National University, Incheon, Korea.ORCID 0000-0001-5101-4339
Heon Yung GeeInstitute for Lee Won Sang Yonsei Ear Science, Seoul, Republic of Korea. hygee@yuhs.ac.ORCID 0000-0002-8741-6177
Jinwoong BokDepartment of Otorhinolaryngology, Brain Korea 21 PLUS Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea. bokj@yuhs.ac.ORCID 0000-0003-1958-1872
Jae Young ChoiDepartment of Otorhinolaryngology, Brain Korea 21 PLUS Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea. jychoi@yuhs.ac.
Je Kyung SeongKorea Mouse Phenotyping Center, Seoul National University, Seoul, Republic of Korea. snumouse@snu.ac.kr.ORCID 0000-0003-1177-6958

Funding

Ministry of Health and Welfare (Ministry of Health, Welfare and Family Affairs) HI21C1576National Research Foundation of Korea (NRF) 2018R1A5A2025079National Research Foundation of Korea (NRF) 2020M3A9D5A01082439National Research Foundation of Korea (NRF) 2020R1A2C3005787National Research Foundation of Korea (NRF) 2022R1A2C3007281Yonsei University | Yonsei University College of Medicine (YUCM) 6-2021-0002Yonsei University | Yonsei University College of Medicine (YUCM) 6-2021-0003Yonsei University | Yonsei University College of Medicine (YUCM) 6-2021-0004
6 · The paper itself

Abstract

Myh1 is a mouse deafness gene with an unknown function in the auditory system. Hearing loss in Myh1-knockout mice is characterized by an elevated threshold for the auditory brainstem response and the absence of a threshold for distortion product otoacoustic emission. Here, we investigated the role of MYH1 in outer hair cells (OHCs), crucial structures in the organ of Corti responsible for regulating cochlear amplification. Direct whole-cell voltage-clamp recordings of OHCs revealed that prestin activity was lower in Myh1-knockout mice than in wild-type mice, indicating abnormal OHC electromotility. We analyzed whole-exome sequencing data from 437 patients with hearing loss of unknown genetic causes and identified biallelic missense variants of MYH1 in five unrelated families. Hearing loss in individuals harboring biallelic MYH1 variants was non-progressive, with an onset ranging from congenital to childhood. Three of five individuals with MYH1 variants displayed osteopenia. Structural prediction by AlphaFold2 followed by molecular dynamic simulations revealed that the identified variants presented structural abnormalities compared with wild-type MYH1. In a heterogeneous overexpression system, MYH1 variants, particularly those in the head domain, abolished MYH1 functions, such as by increasing prestin activity and modulating the membrane traction force. Overall, our findings suggest an essential function of MYH1 in OHCs, as observed in Myh1-deficient mice, and provide genetic evidence linking biallelic MYH1 variants to autosomal recessive hearing loss in humans.

Indexed as

Hair Cells, Auditory, OuterHearing LossMice, KnockoutMyosin Heavy ChainsAdolescentAdultAnimalsChildChild, PreschoolExome SequencingFemaleHumansMaleMicePedigreeMyosin Heavy Chains

Identifiers

PMID39482536
PMCPMC11612406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.